NCT07052513View on ClinicalTrials.gov

Modified Autologous Leukocyte Cells for the Treatment of Acute Kidney Injury After Cardiac Surgery

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

July 17, 2025

Primary Completion Date

June 17, 2027

Study Completion Date

September 2, 2027

Conditions
Acute Kidney Injury
Interventions
DRUG

Placebo

Intravenous infusion of normal saline.

DRUG

M2RLAB 001

Intravenous infusion of M2RLAB 001

Trial Locations (2)

41013

Hospital Univ. Virgen del Rocío, Seville

08036

Hospital Clinic of Barcelona, Barcelona

All Listed Sponsors
lead

M2RLAB SL

INDUSTRY